News

The company has received $10 million as a first tranche of the financing and will receive the remainder of the proceeds in two tranches as specific milestones are

Mr Melchers will replace David Coffin-Beach who resigned from the board of directors in March 2009 for personal reasons. Most recently, Mr Melchers was global CFO of the

This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry (MS), validated by peer-reviewed publications, presentations at international conferences and

EDO-MED will continue to market and provide technical service support for the CT Laser Mammography (CTLM) system throughout Poland, as well as assist with and promote the ongoing

This Phase II, randomized, placebo-controlled trial is designed to investigate whether therapeutic immunization during highly active antiretroviral therapy (HAART) induces elevations of HIV-specific memory T cells in HIV-1-infected

The Retimax reportedly performs innovative tests for the early screening and follow-up of important pathologies like Glaucoma, age related Maculopaty, vascular retinal degeneration and other optic nerve diseases.

Under the licensing and development agreement, Novadaq and Intuitive are working together to integrate Novadaq’s proprietary SPY imaging technology into the 3D high definition imaging capabilities of Intuitive’s

The objectives of this trial will be to assess safety, tolerability and pharmacokinetics of single and multiple ascending doses of VTX-1463 in approximately 30 healthy volunteers. The trial

According to Minnow Medical, the catheter utilizes the company’s Guided Reshaping Technology (GRT) to treat peripheral artery disease (PAD). Minnow said that its GRT treats artery disease by